Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label extension study of cortexolone 17alpha-propionate 1% cream in acne vulgaris
2015-002637-21Phase 3Completed
- Sponsor
- Cassiopea S.p.A.
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clascoterone in acne vulgaris, sponsored by Cassiopea S.p.A. Primary endpoint: Incidence of treatment-emergent adverse events. Started Feb 2016; status: completed.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2015-002637-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002637-21.